| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CA(L) | 140 | 90.9% | -3.81 | 10 | 100.0% |
| CentralBrain-unspecified | 14 | 9.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KC | % In | CV |
|---|---|---|---|---|---|
| DM1_lPN (L) | 1 | ACh | 30 | 20.3% | 0.0 |
| DM2_lPN (L) | 1 | ACh | 27 | 18.2% | 0.0 |
| VA2_adPN (L) | 1 | ACh | 25 | 16.9% | 0.0 |
| VC1_lPN (L) | 1 | ACh | 23 | 15.5% | 0.0 |
| APL (L) | 1 | GABA | 9 | 6.1% | 0.0 |
| LHPV12a1 (R) | 1 | GABA | 8 | 5.4% | 0.0 |
| DM5_lPN (L) | 1 | ACh | 7 | 4.7% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 7 | 4.7% | 0.0 |
| KCab-s (L) | 4 | DA | 5 | 3.4% | 0.3 |
| KCab-m (L) | 2 | DA | 2 | 1.4% | 0.0 |
| KCab-c (L) | 1 | DA | 1 | 0.7% | 0.0 |
| KCg-m (L) | 1 | DA | 1 | 0.7% | 0.0 |
| FB2G_a (L) | 1 | Glu | 1 | 0.7% | 0.0 |
| LHCENT1 (L) | 1 | GABA | 1 | 0.7% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.7% | 0.0 |
| downstream partner | # | NT | conns KC | % Out | CV |
|---|---|---|---|---|---|
| APL (L) | 1 | GABA | 7 | 43.8% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 2 | 12.5% | 0.0 |
| LHMB1 (L) | 1 | Glu | 1 | 6.2% | 0.0 |
| KCab-m (L) | 1 | DA | 1 | 6.2% | 0.0 |
| KCg-m (L) | 1 | DA | 1 | 6.2% | 0.0 |
| KCab-s (L) | 1 | DA | 1 | 6.2% | 0.0 |
| KCa'b'-m (L) | 1 | DA | 1 | 6.2% | 0.0 |
| LHCENT1 (L) | 1 | GABA | 1 | 6.2% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 1 | 6.2% | 0.0 |
